Table 3 Factors associated with mortality in Behçet’s disease
From: Ethnicity and association with disease manifestations and mortality in Behçet’s disease
Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
Parameters | HR (CI 95%) | p | HR (CI 95%) | P |
Age at diagnosis | 1.04 (1.01-1.07) | 0.002 | 1.05 (1.02-1.08) | 0.0007 |
Male gender | 6.87 (2.1-22.3) | 0.001 | 5.01 (1.51-16.65) | 0.0085 |
Ethnic origin | ||||
Europe | 1 | 0.015 | ||
North Africa | 1.93 (0.96-3.85) | |||
Sub Saharan Africa | 3.75 (1.43-9.88) | 2.62 (0.98-6.97) | 0.015 | |
HLA B5 | 0.54 (0.26-1.13) | 0.10 | ||
Oral ulcerations | 0.54 (0.1-2.2) | 0.39 | 0.41 (0.22-0.78) | 0.0069 |
Genital ulcerations | 0.42 (0.22-0.79) | 0.006 | ||
Ocular involvement | 0.81 (0.43-1.54) | 0.53 | ||
CNS involvement | 1.05 (0.55-2) | 0.88 | ||
Articular involvement | 0.8 (0.43-1.54) | 0.49 | ||
Cardiovascular involvement | 2.43 (1.25-4.7) | 0.009 | 2.24 (1.15-4.36) | 0.0184 |
Corticosteroids | 3.3 (1.29-8.43) | 0.013 | ||
Immunosuppressants | 2.35 (1.15-4.8) | 0.020 |